Pharmacology of alpha-conotoxin MII-sensitive subtypes of nicotinic acetylcholine receptors isolated by breeding of null mutant mice
- PMID: 17341654
- DOI: 10.1124/mol.106.031492
Pharmacology of alpha-conotoxin MII-sensitive subtypes of nicotinic acetylcholine receptors isolated by breeding of null mutant mice
Abstract
Subtypes of nicotinic acetylcholine receptors (nAChR) containing alpha6 subunits comprise 25 to 30% of the presynaptic nAChRs expressed in striatal dopaminergic terminals in rodents and 70% in monkeys. This class of receptors, potentially important in nicotine addiction, binds alpha-conotoxin MII (alpha-CtxMII) with high affinity and is heterogeneous, consisting of several subtypes in mice, possibly an important consideration for the design of compounds that selectively activate or antagonize the alpha6 subclass of nAChRs. Selected-null mutant mice were bred to generate isolated subtypes of alpha6beta2* nAChRs expressed in vivo for assessing pharmacology of alpha6beta2* nAChRs. Binding to striatal membranes and function in synaptosomes from (alpha4-/-)(beta3+/+) and (alpha4-/-)(beta3-/-) mice were measured and compared with wild-type (alpha4+/+)(beta3+/+) mice. Gene deletions (alpha4 and beta3) decreased binding of (125)I-alpha-CtxMII without affecting affinity for alpha-CtxMII or inhibition of alpha-CtxMII binding by epibatidine or nicotine. Deletion of the alpha4 subunit substantially increased EC(50) values for both nicotine- and cytisine-stimulated alpha-CtxMII-sensitive dopamine release from striatal synaptosomes. A further increase in EC(50) values was seen upon the additional deletion of the beta3 subunit. The data indicate that one alpha-CtxMII-sensitive nAChR subtype, prevalent on wild-type dopaminergic terminals, has the lowest EC(50) for a nicotine-mediated function so far measured in mice. In conclusion, the gene deletion strategy enabled isolation of alpha6* subtypes, and these nAChR subtypes exhibited differential activation by nicotine and cytisine.
Similar articles
-
Subunit composition and pharmacology of two classes of striatal presynaptic nicotinic acetylcholine receptors mediating dopamine release in mice.Mol Pharmacol. 2004 Jun;65(6):1526-35. doi: 10.1124/mol.65.6.1526. Mol Pharmacol. 2004. PMID: 15155845
-
The subunit composition and pharmacology of alpha-Conotoxin MII-binding nicotinic acetylcholine receptors studied by a novel membrane-binding assay.Neuropharmacology. 2005 Apr;48(5):696-705. doi: 10.1016/j.neuropharm.2004.12.011. Neuropharmacology. 2005. PMID: 15814104
-
Expression of nigrostriatal alpha 6-containing nicotinic acetylcholine receptors is selectively reduced, but not eliminated, by beta 3 subunit gene deletion.Mol Pharmacol. 2005 Jun;67(6):2007-15. doi: 10.1124/mol.105.011940. Epub 2005 Mar 4. Mol Pharmacol. 2005. PMID: 15749993
-
The subtypes of nicotinic acetylcholine receptors on dopaminergic terminals of mouse striatum.Biochem Pharmacol. 2007 Oct 15;74(8):1235-46. doi: 10.1016/j.bcp.2007.07.032. Epub 2007 Jul 27. Biochem Pharmacol. 2007. PMID: 17825262 Free PMC article. Review.
-
Nicotinic receptor antagonists as treatments for nicotine abuse.Adv Pharmacol. 2014;69:513-51. doi: 10.1016/B978-0-12-420118-7.00013-5. Adv Pharmacol. 2014. PMID: 24484986 Free PMC article. Review.
Cited by
-
Scopolamine administration modulates muscarinic, nicotinic and NMDA receptor systems.PLoS One. 2012;7(2):e32082. doi: 10.1371/journal.pone.0032082. Epub 2012 Feb 23. PLoS One. 2012. PMID: 22384146 Free PMC article.
-
A novel α-conotoxin MII-sensitive nicotinic acetylcholine receptor modulates [(3) H]-GABA release in the superficial layers of the mouse superior colliculus.J Neurochem. 2012 Jul;122(1):48-57. doi: 10.1111/j.1471-4159.2012.07759.x. Epub 2012 May 9. J Neurochem. 2012. PMID: 22506481 Free PMC article.
-
Pharmacologically distinct nicotinic acetylcholine receptors drive efferent-mediated excitation in calyx-bearing vestibular afferents.J Neurosci. 2015 Feb 25;35(8):3625-43. doi: 10.1523/JNEUROSCI.3388-14.2015. J Neurosci. 2015. PMID: 25716861 Free PMC article.
-
Synaptic-like axo-axonal transmission from striatal cholinergic interneurons onto dopaminergic fibers.Neuron. 2022 Sep 21;110(18):2949-2960.e4. doi: 10.1016/j.neuron.2022.07.011. Epub 2022 Aug 4. Neuron. 2022. PMID: 35931070 Free PMC article.
-
Extending the analysis of nicotinic receptor antagonists with the study of alpha6 nicotinic receptor subunit chimeras.Neuropharmacology. 2008 Jun;54(8):1189-200. doi: 10.1016/j.neuropharm.2008.03.010. Epub 2008 Mar 28. Neuropharmacology. 2008. PMID: 18448138 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources